YAEL MARGOLIN

Insider Reports History

Location
Indianapolis, IN
Signature
/s/ William L. Demers, by Power of Attorney for Yael Margolin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by YAEL MARGOLIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
BiondVax Pharmaceuticals Ltd. Director Ordinary Shares 66,800 01 Jan 2023 Direct
POINT Biopharma Global Inc. Director Common Stock 0 $12.45 27 Dec 2023 Direct
POINT Biopharma Global Inc. Director Stock Option (Right to Buy) 0 27 Dec 2023 Direct

Insider Reports Filed by YAEL MARGOLIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923129766-margolin-yael-2023-12-27 POINT Biopharma Global Inc. 27 Dec 2023 4 $0 4 Director 27 Dec 2023, 17:35
/report/000110465923068143-margolin-yael-2023-06-01 POINT Biopharma Global Inc. 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 17:35
SCNI BiondVax Pharmaceuticals Ltd. 01 Jan 2023 0 $0 3/A Director 23 Jan 2023, 07:16
/report/000110465922121618-margolin-yael-2022-11-21 POINT Biopharma Global Inc. 21 Nov 2022 1 +$11,218 4 Director 23 Nov 2022, 11:43
/report/000110465922068508-margolin-yael-2022-06-02 POINT Biopharma Global Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:04
/report/000110465921090265-margolin-yael-2021-07-06 POINT Biopharma Global Inc. 06 Jul 2021 1 $0 4 Director 08 Jul 2021, 16:40
/report/000110465921087819-margolin-yael-2021-06-30 POINT Biopharma Global Inc. 30 Jun 2021 0 $0 3 Director 30 Jun 2021, 21:22